Skip to main content
OpenTrials

Clinical trial condition

Metastatic Breast Cancer

Explore clinical trials studying Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

640 public trials 137 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Breast Cancer trial results

Active, Not Recruiting

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

NCT05563220

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Dothan Hematology and Oncology Dothan, Alabama, United States
  • Mayo Clinic - Arizona Phoenix, Arizona, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope National Medical Center Duarte, California, United States
View all 83 locations
View Trial Details
Active, Not Recruiting

Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor

NCT02738866

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Kimmel Cancer Center at Johns Hopkins at Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Anne Arundel Health System Research Institute, Inc. Annapolis, Maryland, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Allegheny Health Network (AHN) - Allegheny General Hospital ONLY Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

NCT06018337

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Research Site 1141-0 Tucson, Arizona, United States
  • Research Site 1114-0 Fullerton, California, United States
  • Research Site 1107-0 Los Angeles, California, United States
  • Research Site 1118-0 Orange, California, United States
View all 258 locations
View Trial Details
Active, Not Recruiting

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

NCT06048718

Conditions
Brain Diseases, Brain Neoplasms, Breast Cancer, +11 more
Locations
  • Salzburg Cancer research Institute-Center Salzburg, Austria
  • Medical University of Vienna Vienna, Austria
  • Hospital Universitario San Juan de Alicante Alicante, Spain
  • Hospital Universitari Dexeus Barcelona, Spain
View all 13 locations
View Trial Details
Active, Not Recruiting

ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study

NCT05596409

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Highlands Oncology Group, PA Springdale, Arkansas, United States
  • Northwestern University, Northwestern Feinberg School of Medicine Prentice Women's Hospital Chicago, Illinois, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • UT Health San Antonio Mays Cancer Center San Antonio, Texas, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

Fulvestrant, Ipatasertib and CDK4/6 Inhibition in Metastatic ER+/HER2- Breast Cancer Patients Without ctDNA Suppression

NCT04920708

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • Addenbrookes Hospital Cambridge, Cambridgeshire, United Kingdom
  • Royal Cornwall Hospital Truro, Cornwall, United Kingdom
  • Mount Vernon Cancer Centre London, Surrey, United Kingdom
  • Velindre Cancer Centre Cardiff, Wales, United Kingdom
View all 13 locations
View Trial Details
Active, Not Recruiting

Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

NCT06590857

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Research Facility Phoenix, Arizona, United States
  • Research Facility Irvine, California, United States
  • Research Facility San Diego, California, United States
  • Research Facility Santa Monica, California, United States
View all 31 locations
View Trial Details

Related conditions